Waters Acquires Thar Instruments
News Feb 06, 2009
Waters Corporation announces acquisition of all the remaining outstanding capital stock of privately held Pittsburgh-based Thar Instruments, Inc., for an undisclosed amount.
Waters® had previously made an equity investment in Thar in June 2007. Thar’s current annual revenues are approximately $18 million, and the acquisition is estimated to be neutral to Waters 2009 earnings.
Considered a leading “green” analytical and purification technology, Thar’s SFC and extraction systems are used to separate, isolate and quantify chemical compounds. The principles of SFC are similar to those of liquid chromatography; however SFC typically uses carbon dioxide as the main mobile phase.
"By combining Thar’s advanced SFC instrumentation with Waters chromatography expertise, Waters is committed to bringing the benefits of SFC to more laboratories for analytical and purification applications worldwide,” said Dr. Rohit Khanna, Vice President, Worldwide Marketing for Waters Division. “Complementing Waters ACQUITY™ UPLC™ environmental position of reduced solvent use without compromised analytical capabilities, SFC expands Waters ‘green’ separation science leadership as customers increasingly demand environmentally friendly options."
Thar products are used in pharmaceutical, life science, chemical and petrochemical companies, as well as government agencies, research institutions and universities. In a world seeking renewable technologies for solving waste and disposal problems, Waters and Thar seek to fill the void with innovative ‘green’ chemistry solutions.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's DiseaseNews
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.READ MORE
New Player in Alzheimer's Disease Pathogenesis IdentifiedNews
Using proteomics, microscopic analysis, and functional assays, scientists have shown that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check.READ MORE